SEC Form 4 · accession 0001144204-16-115763
INTERLEUKIN GENETICS INC · ILIU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth S Kornman
Officer — President and CSO · Director
Period of report
Jul 29, 2016
Accepted (ET)
Aug 1, 2016 · 8:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001037649
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 29, 2016 | P | 25,150 | $0.0994 | A | 400,065 | D | |
| Common StockF1 | holding | — | — | — | 898,723 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Warrant (right to buy) | $0.0994 | Jul 29, 2016 | P | 25,150 | A | Jul 29, 2016 | Jul 29, 2023 | Common Stock | 25,150 | 25,150 | D |
Explanation of responses
- F1Shares held by Rocklyn Ltd., a Texas limited partnership, F.B.O. the Kornman family.
- F2Includes 253,415 shares acquired by Dr. Kornman under the Interleukin Genetics, Inc. Employee Stock Purchase Plans.